ATOSSA THERAPEUTICS, INC. Gain (Loss) on Disposition of Assets
ATOSSA THERAPEUTICS, INC. (ATOS) reported Gain (Loss) on Disposition of Assets of -$163.33 thousand for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-05.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2016-05-05
- ATOSSA THERAPEUTICS, INC. gain (loss) on disposition of assets for the quarter ending 2016-03-31 was -$163.33K.
- ATOSSA THERAPEUTICS, INC. gain (loss) on disposition of assets for the quarter ending 2015-03-31 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 9 month |
|---|---|---|
| 2016-03-31 | -$163.33K 10-Q · filed 2016-05-05 | |
| 2015-09-30 | $74.80K 10-Q · filed 2015-11-12 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-05 | |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |